Leigh's disease: Difference between revisions
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
|||
| Line 18: | Line 18: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 42: | Line 42: | ||
{{reflist}} | {{reflist}} | ||
{{Diseases of the nervous system}} | {{Diseases of the nervous system}} | ||
{{Mitochondrial diseases}} | {{Mitochondrial diseases}} | ||
Revision as of 16:50, 9 August 2012
| Leigh's disease | |
| ICD-10 | G31.8 |
|---|---|
| ICD-9 | 330.8 |
| OMIM | 256000 |
| DiseasesDB | 30792 |
| MeSH | D007888 |
|
WikiDoc Resources for Leigh's disease |
|
Articles |
|---|
|
Most recent articles on Leigh's disease Most cited articles on Leigh's disease |
|
Media |
|
Powerpoint slides on Leigh's disease |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Leigh's disease at Clinical Trials.gov Trial results on Leigh's disease Clinical Trials on Leigh's disease at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Leigh's disease NICE Guidance on Leigh's disease
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Leigh's disease Discussion groups on Leigh's disease Patient Handouts on Leigh's disease Directions to Hospitals Treating Leigh's disease Risk calculators and risk factors for Leigh's disease
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Leigh's disease |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Leigh's disease, a form of Leigh syndrome, also known as Subacute Necrotizing Encephalomyelopathy (SNEM), is a rare neurometabolic disorder that affects the central nervous system. It is named after Denis Archibald Leigh, a British psychiatrist who first described the condition in 1951. [1]
Causes
It is an inherited disorder which usually affects infants, but in rare cases, teenagers and adults, as well. In the case of the disease, mutations in mitochondrial DNA or in nuclear DNA (gene SURF1[2] and some COX assembly factors) cause degradation of motor skills and eventually death.
Mitochondria are some of the most important organelles in animal cells as they provide energy for the cell's function. In humans, their primary function is to convert the potential energy of glucose and fatty acids into that of adenosine triphosphate. The energy in the ATP is then used to carry out virtually all of the cell's metabolic functions. Mitochondria are also unique in that they carry their own type of DNA, mitochondrial DNA, or mtDNA. The information stored in the mtDNA is used in the creation of new mitochondria.
When improper mutations of the mtDNA cause the mitochondria to fail to function properly, a person is at risk for number of disorders, including Leigh's disease. In the case of Leigh's Disease, crucial cells in the brain stem have mutated mtDNA which creates poorly functioning mitochondria. This causes a chronic lack of energy in the cells, which in turn affects the central nervous system and inhibits an individual's motor skills.
Presentation
The disease is most noted for its degradation in a person’s ability to control their movements. As it progresses rapidly, the earliest signs may be poor sucking ability and loss of head control and motor skills. Other symptoms include loss of appetite, vomiting, irritability, continuous crying (in infants), and seizures. A later sign can also be episodes of lactic acidosis, which can lead to impairment of respiratory and kidney function. Some children can present with loss of development skills or developmental regression and have often had investigations for failure to thrive. As the disease progresses in adults, it may also cause general weakness, kidney failure and heart problems. Life expectancy is usually about a year within the onset of symptoms although both acute fulminating illness of a few days and prolonged survival have been reported.
Treatment
It is a very rare disorder which affects only a small portion of the population, and as of yet, there is no cure for Leigh's disease. It usually affects infants under 2 years of age, but, in rarer cases, teenagers and adults as well. A high-fat, low-carbohydrate diet may be recommended. Adults may have puffiness and/or swelling of the eye area and the hands. It is currently treated with Vitamin B1, or thiamin, but even with treatment, infants rarely live longer than two or three years after the onset of the disease. In cases of older people, the disease takes longer, but is still almost always fatal.
X-linked Leigh's disease
There is another form of this disease called the X-linked Leigh's disease which is not a mutation in the oxidative phosphorylation enzymes (which are both on the mtDNA and the nuclear DNA). The X-linked Leigh's disease is a mutation of a gene encoding PDHA1, part of the pyruvate dehydrogenase complex, located on the X chromosome.[3]
References
- ↑ "Obituaries" (PDF). Psychiatric Bulletin (1998). Retrieved 1 Aug 2020.
- ↑ Pronicki M, Matyja E, Piekutowska-Abramczuk D; et al. (2008). "Light and electron microscopy characteristics of the muscle of patients with SURF1 gene mutations associated with Leigh disease". J. Clin. Pathol. 61 (4): 460–6. doi:10.1136/jcp.2007.051060. PMC 2571978. PMID 17908801. Unknown parameter
|month=ignored (help) - ↑ Online Mendelian Inheritance in Man (OMIM) LEIGH SYNDROME, X-LINKED -308930
Template:Diseases of the nervous system
Template:Mitochondrial diseases